Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (265)
2024
-
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma
Frontiers in Immunology, Vol. 15
-
Does success in percutaneous nephrolithotomy depend only on stone size? Analysis of the predictive capacity for success and complications of the current nephrolithometry scoring systems and their relationship with the stone surface
Actas Urologicas Espanolas
-
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7
-
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP
European Journal of Pediatrics
2023
-
Amniotic Membrane Transplantation in the Management of Corneal Ulceration Following Infectious Keratitis
Ocular Immunology and Inflammation
-
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Best practices in phase III clinical trials on DMTs for multiple sclerosis: A systematic analysis and appraisal of published trials
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 4, pp. 333-341
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
-
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™
Neurologia, Vol. 38, Núm. 5, pp. 326-333
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915
-
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869
-
Critical patients COVID-19 has changed the management and outcomes in the ICU after 1 year of the pandemic? A multicenter, prospective, observational study
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 70-78
-
Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 8, pp. 1587-1594
-
Dupilumab in children and adolescents with atopic dermatitis: A case series and literature review
Piel, Vol. 38, Núm. 4, pp. 231-239
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Evidence of publication bias in multiple sclerosis clinical trials: A comparative analysis of published and unpublished studies registered in ClinicalTrials.gov
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 8, pp. 597-604
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204